SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001214659-20-001392
Filing Date
2020-02-14
Accepted
2020-02-14 06:19:18
Documents
1
Group Members
ANDREW J. M. SPOKESDAVID T. KIMFARALLON CAPITAL (AM) INVESTORS, L.P.FARALLON CAPITAL F5 MASTER I, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CA

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 fpt211206sc13ag2.htm SC 13G/A 330401
  Complete submission text file 0001214659-20-001392.txt   333212
Mailing Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111 (415)421-2132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Subject) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89601 | Film No.: 20613613
SIC: 2834 Pharmaceutical Preparations